Webcast Alert: Regulus Therapeutics, Alnylam Pharmaceuticals and Isis Pharmaceuticals Announce New Nature Publication on miR-21 Confe... ( CARLSBAD Calif. Dec. 1 /- Isis Pharma...)

HOME >> BIOLOGY >> TECHNOLOGY

Webcast Alert: Regulus Therapeutics, Alnylam Pharmaceuticals and Isis Pharmaceuticals Announce New Nature Publication on miR-21 Conference Call

Date:12/1/2008

CARLSBAD, Calif., Dec. 1 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announces the following webcast:

    What:   New findings published in the journal Nature on the role of a
            microRNA, known as miR-21, in heart failure

    When:   Monday, December 1, 2008, at 8:30 a.m. ET / 5:30 a.m. PT

    Where: http://www.isispharm.com

    How:    Live on the Internet.  Simply log onto our website listed above.

If you are unable to participate during the live event, a replay of the webcast will be available for a limited time at http://www.isispharm.com.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 19 drugs in development. Isis' drug development programs are focused on treating cardiovascular and metabolic diseases. Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Ibis Biosciences, Inc., Isis' majority-owned subsidiary, is developing and commercializing the Ibis T5000(TM) Biosensor System, a revolutionary system to identify infectious organisms. Isis is a joint owner of Regulus Therapeutics LLC, a joint venture focused on the discovery, development and commercialization of microRNA therapeutics. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,500 issued patents worldwide. Additional information about Isis is available at http://www.isispharm.com.

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Post Your Comments:

(Date:11/5/2009)...LINGTON, Colo., Nov. 5 The endange... in the western U.S. This rare carnivore feeds on...ible to plague and often entire population die-off...rvice (FWS) has implemented a ferret breeding prog...s into their formerly native habitat. Unfortunate...

(Date:11/5/2009)... DIEGO, Nov. 5 Imageneti...y that William Spencer, President and CEO of Image...he 2nd annual LD MICRO Conference on Thursday, Dec...os Angeles. ,, About LD MICRO ,, LD MICRO is... on finding undervalued companies in the micro-cap...

(Date:11/5/2009)...ference Call on Thursday, November 5, 2009 at 4:30...R Nov. 5 /PRNewswire-FirstCall/ - OncoGenex Pharma...SDAQ: OGXI ) today reported unaudited financial r... September 30, 2009 and reviewed the Company,s hig...ollowing consolidated results reflect the operatio...

(Date:11/5/2009)...BROOK, N.Y., Nov. 5 BioS...opharmaceutical company developing first-in-class ...nancial results for the third quarter ended Septem..., in September of this year, the FDA,s Arthritis A...te of 12-0, the approval of XIAFLEX(TM) for the tr...

[0] Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret [0] Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air [0] OncoGenex Reports Third Quarter 2009 Financial Results [0] BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results

... on the past, present and future of Dept. of Comme...up to WTNs interview with Nettles in March 2003....x to 12 months, what Dept. of Commerce initiatives...y Nettles: I had a meeting with Gov. Doyle a coup... Commerces activities: where we are and what were ...

...arolina and Los Angeles become havens for entrepre...of angel investors shared their most effective pra... Milwaukee . , ,Their techniques included educatio...ord, said Monica Doss, president of the Council f...rolinas Research Triangle Park. Entrepreneurs and ...

...ence got off to a dynamic start on Tuesday morning... a hundred entrepreneurs and industry representati...ccess. The entrepreneurial boot camp was designed... providing a loose outline for success from a pane... focus on what were doing here, said Ken Wanek, fo...

Other Biology Technology:WTN exclusive interview with Commerce Secretary Cory Nettles (part 2) 2 WTN exclusive interview with Commerce Secretary Cory Nettles (part 2) 3 WTN exclusive interview with Commerce Secretary Cory Nettles (part 2) 4 WTN exclusive interview with Commerce Secretary Cory Nettles (part 2) 5 Experts share advice for Wisconsin entrepreneur programs 2 Experts share advice for Wisconsin entrepreneur programs 3 Experts share advice for Wisconsin entrepreneur programs 4 Entrepreneurs get crash course for building a successful company 2 Entrepreneurs get crash course for building a successful company 3

WTN exclusive interview with Commerce Secretary Cory Nettles (part 2)Experts share advice for Wisconsin entrepreneur programs Entrepreneurs get crash course for building a successful company

(Date:11/5/2009)... University have developed synthetic molecules cap...V and HIV-infected cells, as well as to prostate c...he Journal of the American Chemical Society , cou...diseases. , The molecules called "antibody-rec...ody-recruiting molecule targeting prostate cancer"...

(Date:11/4/2009)...ildhood obesity in the United States is reaching e...advertising on daytime and prime time television d...ions about the role television plays in obesity, a...nal of Nutrition Education and Behavior examines ...large contributor to the problem. , Researchers ...

(Date:11/4/2009)...ire-FirstCall/ -- Quest Diagnostics Incorporated (...nostic testing, information and services, announce...009, income from continuing operations rose to $19...illion, or $0.81 per diluted share, for the third ...re reduced by a $0.03 per share charge associated ...

[2] New synthetic molecules trigger immune response to HIV and prostate cancer [0] TV bombards children with commercials for high-fat and high-sugar foods [0] Quest Diagnostics Reports Strong Performance in Third Quarter 2009

... has been one of the great mysteries in plant scie...plant growth hormone auxin exists. They,ve known o...ment since the 1930s. But only now do scientists k... University Bloomington biologists Mark Estelle, N...IR1 as the protein that, with auxin, influences ho...

...TH great fanfare a South Korean team announced las...ate human embryonic stem cells that were genetical... could already be obsolete. Another team headed by...tute, based in Chicago, claims to have produced pa...ng to therapeutic cloning. "It would be a much bet...

...ilent Technologies Inc. (NYSE: A) and Proteome Sys...today announced they have signed a marketing agree...the analysis of glycoproteins, molecules that are ... cancer, influenza and arthritis. Under the agreem...are, a comprehensive platform for the mass spectro...

Other Biology News:At long last, scientists figure out how plants grow 2 Double triumph in stem cell quest 2 Double triumph in stem cell quest 3 Double triumph in stem cell quest 4 Integration of Agilent's MS technology, Proteome Systems' software to help scientists in proteomics research 2

At long last, scientists figure out how plants grow Double triumph in stem cell quest Integration of Agilent's MS technology, Proteome Systems' software to help scientists in proteomics research

GenomePlex Single Cell Whole Genome Amplification Kit from Sigma-Aldrich

Mouse Anti-Human QARS Monoclonal Antibody, Unconjugated, Clone 5F5 from Novus Biologicals

Rabbit Anti-Mouse Ym1 Polyclonal Antibody, Unconjugated from StemCell Technologies, Inc.

Calf Serum, Iron-Supplemented from Sigma-Aldrich

Biology Products:

GenomePlex Single Cell Whole Genome Amplification Kit from Sigma-Aldrich Mouse Anti-Human QARS Monoclonal Antibody, Unconjugated, Clone 5F5 from Novus Biologicals Rabbit Anti-Mouse Ym1 Polyclonal Antibody, Unconjugated from StemCell Technologies, Inc.Calf Serum, Iron-Supplemented from Sigma-Aldrich

Webcast Alert: Regulus Therapeutics, Alnylam Pharmaceuticals and Isis Pharmaceuticals Announce New Nature Publication on miR-21 Confe...( CARLSBAD Calif. Dec. 1 /- Isis Pharma...)